Phosphorylation of myosin II regulatory light chain (MRLC) is important for cell motility and cytokinesis in nonmuscle cells. Although the regulation of monophosphorylated MRLC at serine 19 throughout the cell cycle was examined in detail, MRLC diphosphorylation at both threonine 18 and serine 19 is still unclear. Here we found that Rho-kinase has an activity for MRLC diphosphorylation in nonmuscle cells using sequential column chromatographies. Transfection of Rho-kinase-EGFP induced the excess diphosphorylated MRLC and the bundling of the actin filaments. Conversely, the treatment of cells with a specific inhibitor of Rho-kinase, Y-27632, resulted in the decrease of endogenous diphosphorylated MRLC and actin stress fibers. Immunolocalization studies showed that both diphosphorylated MRLC and Rho-kinase accumulated and colocalized at the contractile ring and the midbody in dividing cells. Taken together, it is suggested that Rho-kinase contributes to MRLC diphosphorylation and reorganization of actin filaments in nonmuscle cells.
Introduction
Phosphorylation of the regulatory light chain of myosin II (MRLC) is considered to modulate the cellular function in several types of cells, such as smooth muscle cells (Sakurada et al., 1998) , platelets (Itoh et al., 1992) and cultured nonmuscle cells (Goeckeler and Wysolmerski, 1995; Matsumura et al., 1998; Murata-Hori et al., 1998) . Phosphorylation of MRLC regulates the actin-activated MgATPase activity of myosin II (Ikebe and Hartshorne, 1985, Trybus, 1989 ) and the assembly of myosin II in vitro and in vivo (Applegate and Pardee, 1992; Kolega and Kumar, 1999) . The phosphorylation sites of MRLC by myosin light chain kinase (MLCK) are mainly serine 19 (monophosphorylation) and, in some conditions, both threonine 18 and serine 19 (diphosphorylation) (Ikebe et al., 1986) and the phosphorylation at both sites resulted in higher MgATPase activity of myosin II than that of single site phosphorylated myosin II (Ikebe, 1989) .
The regulation of monophosphorylated MRLC throughout the cell cycle was examined in detail. Immunolocalization studies demonstrated that monophosphorylated MRLC in nonmuscle cells has roles in cell motility and cytokinesis Murata-Hori et al., 1998) . Furthermore, the inhibition of Rho-kinase induced the decrease in MRLC monophosphorylation along stress fibers in interphase cells (Totsukawa et al., 2000) and at a contractile ring in dividing cells (Kosako et al., 2000) , suggesting that MRLC monophosphorylation was regulated by Rho-kinase. On the other hand, there are several reports that MRLC diphosphorylation has important roles in nonmuscle cells. In thrombinstimulated isometric contraction of human umbilical vein endothelial cells, MRLC diphosphorylation reached the higher level than did monophosphorylation (Goeckeler and Wysolmerski, 1995) . Transfection of ZIP kinase induced MRLC diphosphorylation and aggregation of actin filaments in the cells (Murata-Hori et al., 2001) . However, the regulation of MRLC diphosphorylation throughout the cell cycle is still unclear.
Rho-kinase is one of the direct targets for the small GTPase Rho that regulates actomyosin mediated cellular processes, such as morphology (Paterson et al., 1990) , cell motility (Takaishi et al., 1994) , formation of stress fibers and focal adhesions (Paterson et al., 1990; Ridley and Hall, 1992) , cytokinesis (Kishi et al., 1993; Mabuchi et al., 1993) and tumor cell invasion (Yoshikawa et al., 1998) . Previously, it was reported that Rho-kinase had an ability to induce predominantly MRLC monophosphorylation in vitro . It is also demonstrated that the level of monophosphorylated MRLC was regulated by both Rho-kinase and myosin phosphatase . Conversely, the biological significance and regulation of MRLC diphosphorylation by Rho-kinase are still unknown. Here, we purified and identified Rho-kinase as a kinase capable of diphosphorylating MRLC from HeLa cell extracts. Our results suggest that MRLC diphosphorylation by Rho-kinase contributed to reorganization of actin filaments in nonmuscle cells.
Results

Purification and identification of Rho-kinase as a diphosphorylating MRLC kinase
We tried to purify kinases that induce MRLC diphosphorylation from HeLa cell extracts using sequential chromatographies (Figure 1 ). Diphosphorylation activity for MRLC was detected using immunoblot analysis with PP1 antibody specific for the diphosphorylated MRLC (Murata-Hori et al., 2001) followed by the total phosphorylation activity for MRLC. Three peaks of diphosphorylation activities for MRLC were detected and they were designated as peaks I (fractions #3 to 10), II (fractions #32 to 36) and III (fractions #42 to 46), respectively ( Figure 1A ). Because the peak II revealed the highest activity, the fractions including the peak II were applied on a hydroxyapatite column. Hydroxyapatite column chromatography results in the appearance of one peak (fractions #39 to 45) of diphosphorylation activity for MRLC ( Figure 1B) . The fractions containing the diphosphorylation activity for MRLC were concentrated and applied on a gel filtration column. As the result of the gel filtration, only a peak of the diphosphorylation activity for MRLC was also eluted ( Figure 1C) . Eventually, we found that the fractions containing the diphosphorylation activity for MRLC consisted of two components, the molecular mass of which were 250 kDa (p250, asterisk in Figure 1D ) and 160 kDa (p160, arrowhead in Figure 1D ), respectively. N-terminal amino acid sequences of three digests derived from p160 and one digest from p250 were determined (Table 1) . Amino acid sequences determined from p160 were highly homologous to Rhoassociated kinase, such as bovine Rho-kinase (Matsui et al., 1996) (92 -100%), mouse ROCK-II (Nakagawa et al., 1996) (89 -100%) and rat ROK a (Leung et al., 1995) (89 -100%) . Amino acid sequence of a peptide from p250 was an exact match to human filamen 1 Figure 1 Purification of a kinase capable of diphosphorylating MRLC from HeLa cells. A kinase, which has activity for MRLC diphosphorylation, was purified from HeLa cell extracts using sequential column chromatographies on Resource Q (A), hydroxyapatite (B) and Superdex 200HR gel filtration (C), respectively. Each fraction was assayed for MRLC phosphorylation activity (closed circle) and the absorbance at 280 nm wavelength (open circle). Lower panels show immunoblot analyses with the antibody against diphosphorylated MRLC for further detection of the activity, which diphosphorylates MRLC. Arrowheads shown in (C) indicate molecular weight markers. Bars in graphs indicate the peaks of activities which diphosphorylate MRLC. The numbers on lower panels show fraction numbers. (D) Aliquots of the fractions on gel filtration were resolved by SDS -PAGE (8%) followed by silver staining. The numbers on panel show fraction numbers. Asterisk and closed arrowhead indicate the components of 250 kDa (p250) and 160 kDa (p160), respectively (ABP-280) (Gorlin et al., 1990) . These results showed that Rho-kinase has an activity for MRLC diphosphorylation in nonmuscle cells.
HeLa Rho-kinase induced MRLC diphosphorylation
Rho-kinase was immunoprecipitated with anti-Rhokinase antibody from HeLa cell extracts (Figure 2A) . CBB staining and immunoblotting with anti-Rhokinase antibody detected a 160-kDa band (arrowhead in Figure 2A ). To confirm that Rho-kinase diphosphorylates MRLC of intact myosin II, intact myosin II was incubated with immunopurified Rho-kinase ( Figure 2B, lanes 1 and 2) . MRLC of intact myosin II was phosphorylated by immunopurified Rho-kinase ( Figure 2B , lane 2 top). Moreover, the phosphorylated MRLC by immunopurified Rho-kinase was reacted with PP1 antibody ( Figure 2B , lane 2 middle). These suggest that HeLa Rho-kinase has an ability to induce MRLC diphosphorylation. The ability of Rho-kinase to diphosphorylate MRLC was confirmed by the experiments using recombinant MRLCs ( Figure 2B , lanes 3 -5). Immunopurified Rho-kinase phosphorylated GST-wtMRLC2 but not GST-MRLC2 T18AS19A (substitution of alanine for both threonine 18 and serine 19) and phosphorylated GST-wtMRLC2 was reacted with PP1 antibody ( Figure 2B , lane 3 middle), indicating that Rho-kinase can diphosphorylate MRLC at both threonine 18 and serine 19. GST-MRLC2 S19A (substitution of alanine for serine 19) was slightly phosphorylated by Rho-kinase ( Figure 2B , lane 5 top).
We next examined what percent of MRLC is diphosphorylated by Rho-kinase in vitro. MRLC phosphorylated by Rho-kinase was separated by urea/glycerol PAGE ( Figure 2C ). At incubation for 60 min, 70% of monophosphorylation and 30% of diphosphorylation were observed. Incubation for 120 min induced 50% of diphosphorylated MRLC.
To further confirm whether Rho-kinase contributes to diphosphorylation of MRLC in HeLa cells, MRLC was phosphorylated by HeLa cell extracts depleted with anti-Rho-kinase antibody ( Figure 2D ). Depletion of Rho-kinase caused 30% decrease in diphosphorylated MRLC ( Figure 2D , top), suggesting that Rhokinase is one of kinases capable of diphosphorylating MRLC in HeLa cells.
Overexpression of Rho-kinase induced the excess diphosphorylated MRLC in the cells
Previously, we reported that the excess diphosphorylated MRLC caused striking bundling of actin filaments in the cells (Murata-Hori et al., 2001) . Thus, we speculated that overexpression of Rho-kinase may induce the excess diphosphorylated MRLC and therefore bundling of actin filaments. To address this, Rhokinase-EGFP was transfected into HeLa cells. First, immunoprecipitated Rho-kinase-EGFP was subjected to MRLC kinase activity assay. As shown in Figure  3A , Rho-kinase-EGFP was able to phosphorylate MRLC and the phosphorylated MRLC could be The sequences are given using the single letters abbreviations for amino acids. X indicates a residue that could not be identified unequivocally. Accession numbers of a, b, c and d are S70633, S74245, U38481-1 and P21333, respectively Diphosphorylation of myosin II by Rho-kinase K Ueda et al detected by PP1 antibody, suggesting that Rho-kinase-EGFP has the ability to diphosphorylate MRLC. Next, we transfected Rho-kinase-EGFP into HeLa cells, incubated in the serum-free medium and then doubly stained the cells with PP1 antibody and CPITC labeled-phalloidin ( Figure 3B ). In the cells transfected with Rho-kinase-EGFP, the filamentous structures of the diphosphorylated MRLC and thick actin filaments were observed ( Figure 3B ,b and c), while those were hardly observed in the control cells transfected with EGFP ( Figure 3B ,e and f). These suggest that Rhokinase could induce reorganization of actin filaments through MRLC diphosphorylation.
Inhibition of Rho-kinase activity caused decrease of the diphosphorylated MRLC in the cells
To elucidate whether endogenous Rho-kinase contributes to MRLC diphosphorylation in intact cells, HeLa cells (Figure 4a ,b) were treated with 10 mM Y-27632, a specific inhibitor of Rho-kinase, and stained with PP1 antibody and CPITC-phalloidin. When cells were treated with Y-27632, the diphosphorylated MRLC clearly decreased and actin stress fibers concomitantly disrupted (Figure 4b ). These clearly show that Rho-kinase contributed to organization of actin stress fibers through MRLC diphosphorylation in the cells. Because it has also reported that Rho-kinase induced the phosphorylation of MRLC through the inhibition of myosin phosphatase activity Feng et al., 1999) , we next examined whether MRLC diphosphorylation could be due to the inhibition of myosin phosphatase and/or the direct phosphorylation of MRLC by Rho-kinase. Treatment of HeLa cells with only 2 nM calyculin A, a phosphatase inhibitor, caused the increase of diphosphorylated MRLC and bundling of the actin stress fibers (Figure 4c,d) , as compared with the control cells (Figure 4g,h ). This suggests that the increase in diphosphorylated MRLC was induced by the inhibition of myosin phosphatase activity. Strikingly, when we treated HeLa cells with both calyculin A and Y-27632 (Figure 4e,f) , diphosphorylated MRLC was decreased and the actin stress fibers were disrupted in the center of cells. These suggest that Rho-kinase induced MRLC diphosphorylation through direct phosphorylation of MRLC in interphase cells.
Diphosphorylated MRLC and Rho-kinase colocalized at the contractile ring in dividing cells
To examine whether diphosphorylated MRLC was colocalized with Rho-kinase, mitotic HeLa cells stained with PP1 antibody and anti-Rho-kinase antibody were observed using a confocal laser scan microscope. From telophase to the end of cytokinesis, both diphosphorylated MRLC and Rho-kinase accumulated and colocalized at the contractile ring (Figure 5a -f ) and the midbody (Figure 5g -i) . These suggest that Rhokinase diphosphorylates MRLC at the contractile ring in cytokinesis.
Discussion
Regulation of diphosphorylated MRLC in nonmuscle cells
As shown in Figure 1A , several activities including peak II (Rho-kinase) to diphosphorylate MRLC were detected in HeLa cell extracts. Further, the immunoabsorption experiment ( Figure 2D ) revealed that Rhokinase is responsible for just 30% of total activities of MRLC diphosphorylation in HeLa cell extracts. These suggest that other kinases in addition to Rho-kinase may contribute to MRLC diphosphorylation in HeLa cells. It should be elucidated whether peak I and III in Figure 1A contain Rho-kinase and/or ZIP kinase, a serinethreonine kinase which can diphosphorylate MRLC as previously described (Murata-Hori et al., 2001) .
We also showed the localization of diphosphorylated MRLC in the nucleus and the peripheral region of HeLa cells in the presence of the Rho-kinase inhibitor (Figure 4e ). When PP1 antibody was absorbed with an antigen, the nucleus staining was decreased (data not shown). This suggests that localization of diphosphorylated MRLC in the nucleus is specific, although the meaning of the existence of diphosphorylated MRLC in the nucleus is unclear. Totsukawa et al. showed that MLCK but not Rho-kinase is likely to be responsible for phosphorylation of MRLC at the cell periphery (Totsukawa et al., 2000) . These suggest that other kinase(s) such as MLCK contribute diphosphorylation in the nucleus and the peripheral region of the cells.
Several groups reported that Rho-kinase also phosphorylates myosin binding subunit of myosin phosphatase and inhibits myosin phosphatase activity in vitro Feng et al., 1999) . Totsukawa et al. (2000) reported that the inhibition of myosin phosphatase in the cell induced the increase in monophosphorylated MRLC and many actin stress fibers. In the presence of Rho-kinase inhibitor, the increase of them was shown to be blocked in the center of cells. These results demonstrate that the inhibition of myosin phosphatase by Rho-kinase is essential for stress fiber assembly in the center of cells. Here, we showed that the inhibition of Rho-kinase reduced diphosphorylated MRLC in the center of cells even in the presence of phosphatase inhibitor, suggesting that Rho-kinase directly diphosphorylates MRLC (red arrow in Figure   Figure 4 Diphosphorylation of MRLC was regulated by both Rho-kinase and myosin phosphatase in HeLa cells. HeLa cells treated with 10 mM Y-27632 (a, b), 2 nM calyculin A (c, d) and both 2 nM calyculin A and 10 mM Y-27632 (e, f) for 60 min. As a control, cells were treated with 0.1% DMSO (g, h). These cells were stained with PP1 antibody (a, c, e and g), and CPITC labeled-phalloidin (b, d, f and h) 6). Taken together, we propose a model of diphosphorylation of MRLC through dual pathways of both the direct phosphorylation and the inhibition of myosin phosphatase by Rho-kinase ( Figure 6 ).
Roles of diphosphorylated MRLC induced by Rho-kinase
Here, we found that Rho-kinase induces MRLC diphosphorylation and reorganization of actin filaments in interphase cells. We previously reported that the excess amount of diphosphorylated MRLC by ZIPkinase induced a large aggregate of actin filaments in the cells (Murata-Hori et al., 2001) . However, overexpression of wild type Rho-kinase did not induce the aggregation of actin filaments (Figure 3b ). Because ZIP kinase has a higher activity of MRLC phosphorylation than Rho-kinase in vitro (Murata-Hori et al., 2001) . Interestingly, overexpression of constitutively active Rho-kinase induced aggregation of actin stress fibers . These results suggest that the activity of Rho-kinase to reorganize actin filaments is controlled in the cells.
Rho-kinase regulates actin stress fibers and focal adhesions in several types of the cells (Leung et al., 1996; Amano et al., 1997; Ishizaki et al., 1997) and cell migration (Ai et al., 2001) . It was also reported that invasion of cancer cells requires cell motility and adhesion (Helige et al., 1997) . These suggest that Rho-kinase plays important roles in invasion and metastasis of cancer cells. It was revealed that the inhibition of Rho-kinase reduced the level of phosphorylated MRLC and the activity of invasion of tumor cells (Itoh et al., 1999; Somlyo et al., 2000) , suggesting that phosphorylation of MRLC by Rhokinase is required for tumor cell invasion. Furthermore, several reports show that cell migration/invasion requires MRLC phosphorylation by MLCK (Cho and Klemke, 2000; Kaneko et al., 2002) . These suggest that the regulation of actin cytoskeleton through MRLC diphosphorylation may be essential for tumor cell invasion. Yasui et al. (1998) reported that expression of the dominant-negative form of Rho-kinase inhibited cytokinesis and increased in the multi-nuclei cells, suggesting that Rho-kinase plays an important role in cytokinesis. Here, we demonstrated that Rho-kinase diphosphorylates MRLC and colocalizes with the diphosphorylated MRLC at the cleavage furrow in dividing HeLa cells. Other substrates phosphorylated by Rho-kinase have been reported to accumulate at the cleavage furrow in dividing non-muscle cells (Yasui et al., 1998; Kawano et al., 1999) . Recently, Kosako et al. (2000) reported that Rho-kinase is involved in cytokinesis through the monophosphorylation of MRLC and not ERM at the cleavage furrow. It is necessary to elucidate what Rho-kinase mainly phosphorylates at the cleavage furrow of dividing cells. Furthermore, it is still unclear which of mono-and diphosphorylation of MRLC is more important in regulating cytokinesis and/or tumor invasion. In future, further elucidations are required to understand the physiological function of diphosphorylated MRLC.
Materials and methods
Materials and chemicals
Myosin II, the light chains of myosin II (MLCs) and MLCK were purified from chicken gizzards according to the method described previously (Murata-Hori et al., 1998) . Calmodulin (CaM), calyculin A, Coomassie Brilliant Blue (CBB) R250, guanosine 5'-o-(3-thiotriphosphate) (GTP-gS) and Coumarin phenyl isothiocyanate (CPITC) labeled-phalloidin were purchased from Sigma. Cyanogen bromide (CNBr), phenylmethylsulphonyl fluoride (PMSF) and formaldehyde were from Wako Pure Chemical Industries. The goat polyclonal antibody against Rho-kinase was from Santa Cruz. Rhokinase inhibitor, Y-27632, was kindly provided by Welfide Corporation (Uehata et al., 1997) . RhoA protein as GST fusion protein was expressed in E. coli cells as described previously (Suizu et al., 2000) . Human RhoA cDNA was inframe inserted into pGEX-2TK vector (Amersham Pharmacia Biotech).
Cell culture
HeLa cells (RCB0007) were obtained from the Riken Cell Bank (Tsukuba, Japan). They were cultured in MEM (Nissui) containing 10% fetal bovine serum (Intergen).
Purification of diphosphorylating MRLC kinase
HeLa cell extracts were prepared as described previously (Murata-Hori et al., 2001) . It was applied on a Resource Q anion exchange column (6 ml, Amersham Pharmacia Biotech), which was equilibrated with 10 mM Tris-HCl (pH 8.0), 100 mM KCl, 5 mM MgCl 2 , 1 mM EGTA and 1 mM PMSF. The column was eluted with a 100 -500 mM KCl linear gradient using a FPLC system (Amersham Pharmacia Biotech). The Resource Q fractions eluted at 180 mM KCl (named peak II) were pooled and applied on a hydroxyapatite column (CHT2-I; 1 ml, Bio-Rad), which was equilibrated with 10 mM potassium phosphate (pH 7.0), 2 mM MgCl 2 and 1 mM PMSF. The column was eluted with 10 -500 mM potassium phosphate linear gradient using a FPLC system. The hydroxyapatite fractions eluted at 280 mM potassium phosphate were pooled and concentrated by Centricon TM 10 (Amicon). This was loaded on a Superdex 200HR 10/30 gel filtration column (Amersham Pharmacia Biotech), which was equilibrated with 10 mM Tris-HCl (pH 8.0), 200 mM KCl, 5 mM MgCl 2 , 1 mM EGTA and 1 mM PMSF.
In vitro MRLC kinase assay
Phosphorylation assay of fractions (14 ml) from the Resource Q column was carried out for 30 min at 308C in 20 ml of reaction mixture (10 mM Tris-HCl (pH 8.0), 4 mM MgCl 2 , 12 mM NaCl, 0.8 mM EGTA, 1 mM CaCl 2 , 50 mg/ml CaM, 0.1 mM calyculin A and 0.2 mM [g-32 P]ATP (0.1 mCi/ml)) containing 0.06 mg/ml MLCs. Phosphorylation assay of fractions (14 ml) from the hydroxyapatite column was carried out in 20 ml of reaction mixture (30 mM Tris-HCl (pH 8.0), 2 mM MgCl 2 , 10 mM NaCl, 0.1 mM EGTA, 1 mM CaCl 2 , 50 mg/ml CaM, 0.1 mM calyculin A and 0.2 mM [g-32 P]ATP). Phosphorylation assay of fractions (14 ml) from the gel filtration column was carried out in 20 ml of reaction mixture (30 mM Tris-HCl (pH 8.0), 4 mM MgCl 2 , 10 mM NaCl, 140 mM KCl, 0.8 mM EGTA, 1 mM CaCl 2 , 50 mg/ml CaM, 0.1 mM calyculin A and 0.2 mM [g-32 P]ATP). Five micro liter of 56SDS sample buffer (Murata-Hori et al., 1998) was added to the reaction mixture to stop the reaction. These samples were electrophoresed on SDS -PAGE, and the bands of 20 kDa corresponding to MRLC were excised from the gel. The radioactivity of the gel slices was determined by a Cerenkov counting with a scintillation counter (LSC-5100; Aloka). MRLC diphosphorylation activity was detected by immunoblotting with PP1 antibody.
Amino acid sequence analysis
Gel filtration fractions (#17 to 19) were pooled and resolved by SDS -PAGE. The bands corresponding to 160 kDa and 250 kDa were cut off from the gel and partially digested with CNBr, respectively. These digests were electrophoresed on SDS -PAGE and were transferred to PVDF membrane (Immobilon-P SQ , Millipore). The membranes were stained with CBB and destained with 90% methanol and 7% acetic acid. Each peptide was subjected to a protein sequencer (Procise 494 cLC Protein Sequencing System).
Phosphorylation assay of immunopurified Rho-kinase in vitro
HeLa Rho-kinase was immunoprecipitated with anti-Rhokinase antibody as described previously (Hino et al., 2000) . HeLa cell extracts in Triton/glycerol solution were centrifuged at 100 000 g for 2 h in order to precipitate actin cytoskeleton. The supernatant was preadsorbed with protein G-Sepharose beads (Amersham Pharmacia Biotech) for 1 h at 48C. Then the supernatant was incubated with anti-Rhokinase antibody for 1 h at 48C. Fresh protein G-Sepharose beads were added to the mixture, and incubated for an additional 1 h at 48C. The pellet obtained by centrifugation at 1600 g for 5 min at 48C was washed three times with PBS and resolved in 5 mM Tris-HCl (pH 7.5), 5 mM MgCl 2 . Phosphorylation of intact myosin II by Rho-kinase (10.5 mg/ml) was carried out for 30 min at 308C in 20 ml of reaction mixture (50 mM PIPES (pH 6.5), 3 mM MgCl 2 , 60 mM KCl, 1 mM EGTA, 1 mM glutathion, 0.5 mM calyculin A and 1 mM [g-32 P]ATP) containing 0.68 mg/ml myosin II. Phosphorylation of GST-MRLC recombinants (GSTwtMRLC2  and  GST-MRLC2   T18AS19A and GST-MRLC2 S19A ) (Suizu et al., 2000) by Rho-kinase (10.5 mg/ ml) was carried out for 30 min at 308C in 20 ml of reaction mixture (50 mM PIPES (pH 6.5), 3 mM MgCl 2 , 47 mM KCl, 1 mM EGTA, 1 mM glutathione, 0.5 mM calyculin A and 1 mM [g-32 P]ATP) containing 0.11 mg/ml GST-MRLC fusion protein with 0.03 mg/ml GST-RhoA and 0.6 mM GTP-gS. Phosphorylation of MLCs by Rho-kinase (4.8 mg/ml) was carried out for 0, 60 and 120 min at 308C in 20 ml of reaction mixture (50 mM PIPES (pH 6.5), 3.3 mM MgCl 2 , 40 mM NaCl, 20 mM KCl, 1 mM EGTA, 0.6 mM glutathion, 0.5 mM calyculin A and 1 mM ATP) containing 0.24 mg/ml myosin II with 0.03 mg/ml RhoA and 0.6 mM GTP-gS.
HeLa cell extracts in Triton/glycerol solution (0.9 mg) were absorbed with or without anti-Rho-kinase antibody (10 mg). Phosphorylation of MLCs by HeLa cell extracts was carried out for 30 min at 308C in 20 ml of reaction mixture (70 mM PIPES (pH 6.5), 0.6 mM KH 2 PO 4 , 3 mM Na 2 HPO 4 , 6 mM MgCl 2 , 60 mM NaCl, 1 mM KCl, 1.1 mM EGTA, 0.5 mM calyculin A, 0.5 mM ocadaic acid and 1 mM ATP) containing 0.06 mg/ml MLCs.
The radiolabeled bands were visualized by a Bio Imaging Analyzer BAS 2000 (Fuji Photo Film, Tokyo, Japan). MRLC diphosphorylation activity was detected by immunoblotting with PP1 antibody.
Expression of human Rho-kinase as EGFP fused protein
A human brain gene of KIAA0619 (DDBJ, EMBL and GenBank accession no. AB014519) was kindly provided by Kazusa DNA Research Institute (Chiba, Japan) (Ishikawa et al., 1998) . The amino acids encoded by this gene were 98% homologous to those of bovine brain Rho-kinase (Matsui et al., 1996) . Therefore, we identified this gene as human Rhokinase. Human Rho-kinase was expressed as enhanced green fluorescent protein (EGFP) fused protein using pEGFP-N1 (Clontech). The full length of human Rho-kinase was fused to the N-terminus of EGFP under the control of the CMV-IE promoter. HeLa cells were transfected with 1 mg of expression plasmid by lipofection with Lipofectamine (Gibco -BRL). After the cells were incubated with Lipofectamine-DNA complexes for 4 h, medium was replaced with fresh Opti-MEM (Gibco -BRL) and the cells were incubated for another 16 h. As a control, pEGFP-C1 (Clontech), the original vector encoding EGFP, was employed.
Immunoprecipitation of Rho-kinase-EGFP and protein kinase assay Rho-kinase-EGFP and EGFP were immunoprecipitated from transfected HeLa cells using Living Colors TM peptide antibody (Clontech), respectively. Immunoprecipitation was performed as described above, except RIPA buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% DOC, 0.1% SDS) was used as a lysis buffer of HeLa cells. Rhokinase-EGFP and EGFP were incubated with 0.06 mg/ml MLCs in a reaction mixture (40 mM Tris-HCl (pH 7.5) 5 mM MgCl 2 , 80 mM KCl, 20 mM NaCl, 1 mM EGTA, 0.5 mM calyculin A and 1 mM [g-32 P]ATP). The radiolabeled bands were visualized by a Bio Imaging Analyzer BAS 2000. MRLC diphosphorylation activity was detected by immunoblotting with PP1 antibody.
Indirect immunofluorescence
Indirect immunofluorescence analysis was performed as described elsewhere (Murata-Hori et al., 1998) . Briefly, cells grown on coverslips were fixed with 3.7% formaldehyde for 15 min and permeabilized with 0.2% Triton X-100 for 15 min at room temperature. After the cells blocked with 1% bovine serum albumin, the cells were stained with suitable antibodies. The stained cells were analysed by a fluorescence microscope (Nikon Eclipse TE300). In one experiment, HeLa cells grown on coverslips were treated with 0.25 mg/ml nocodazole (Acros Organics) for 4 h. After washing, cells were incubated for 2 h in MEM containing 10% fetal bovine serum to allow cell cycle progression. For double staining with anti-Rho-kinase antibody and PP1 antibody, cells were fixed with 3.7% formaldehyde for 15 min on ice and permeabilized with acetone for 30 s at 7208C. Stained cells were examined with a Zeiss laser scan microscope. Fluorescent images were processed with a custom software.
Other procedures
Silver staining was performed according to the method of Silver Staining Kit (Wako Pure Chemical Industries). Glycerol PAGE, SDS -PAGE, immunoblot analysis and affinity purification of an antibody were described in detail previously (Murata-Hori et al., 1998) .
